Clinigence Holdings (NUTX) Stock Statistics & Valuation Metrics

Clinigence Holdings has a market cap or net worth of $797.71M. The enterprise value is ―.

Clinigence Holdings has 7,071,916 shares outstanding. The number of shares has decreased by -2.65% in one year.

Clinigence Holdings’s return on equity (ROE) is 0.36 and return on invested capital (ROIC) is 20.91%.

The current PE Ratio of Clinigence Holdings is 5.9. Clinigence Holdings’s PEG ratio is -0.02.

In the last 12 months, Clinigence Holdings had revenue of 479.95M and earned 52.18M in profits. Earnings per share was 10.23.

In the last 12 months, operating cash flow was 224.79M and capital expenditures -1.51M, giving a free cash flow of 224.03M billion.

Clinigence Holdings pays an annual dividend of ―, resulting in a dividend yield of ―

Clinigence Holdings upcoming earnings date is Mar 26, 2026, TBA (Confirmed).

Clinigence Holdings as a current ratio of 2.08, with Debt / Equity ratio of 103.33%

In the past 12 months, Clinigence Holdings has paid 14.48M in taxes.

Clinigence Holdings EV to EBITDA ratio is 3.08, with an EV/FCF ratio of 21.98.

Clinigence Holdings has $166.05M in cash and marketable securities with $358.60M in debt, giving a net cash position of -$192.55M billion.

Gross margin is 55.01%, with operating margin of 27.22%, and net profit margin of 10.87%.

The average price target for Clinigence Holdings is $265.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy